Concepedia

Brian Lasonde

BL

Statistics

Publications

3

Citations

114

H-Index

3

Active since

2011

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Harvard University

Dana-Farber Cancer Institute

Brian Lasonde is an author at Memorial Sloan Kettering Cancer Center specializing in radiation oncology, ovarian cancer, and cancer therapeutics.

Top concepts

Publications per year

2011–2014

3

Publications

3

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer

Ursula A. Matulonis, Julie Lee, Brian Lasonde et al. · European Journal of Cancer · 2012 · 45 citations

, , +7

Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).

Ursula A. Matulonis, Gerburg M. Wulf, Michael J. Birrer et al. · Journal of Clinical Oncology · 2014 · 36 citations

A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer.

R. T. Penson, Charles J. Whalen, Brian Lasonde et al. · Journal of Clinical Oncology · 2011 · 33 citations

1–3 of 3